(NYSE: CBT) Cabot's forecast annual revenue growth rate of 2.9% is not forecast to beat the US Specialty Chemicals industry's average forecast revenue growth rate of 4.68%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.78%.
Cabot's revenue in 2026 is $3,634,000,000.On average, 8 Wall Street analysts forecast CBT's revenue for 2026 to be $192,015,715,033, with the lowest CBT revenue forecast at $184,374,325,997, and the highest CBT revenue forecast at $206,007,717,930. On average, 8 Wall Street analysts forecast CBT's revenue for 2027 to be $198,004,911,845, with the lowest CBT revenue forecast at $186,904,245,340, and the highest CBT revenue forecast at $211,428,973,665.
In 2028, CBT is forecast to generate $204,562,049,734 in revenue, with the lowest revenue forecast at $192,945,073,159 and the highest revenue forecast at $220,361,137,876.